GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,117,000 | -16.3% | 30,871 | -8.5% | 0.12% | -10.7% |
| Q4 2021 | $1,334,000 | -14.7% | 33,739 | -5.7% | 0.14% | -20.0% |
| Q3 2021 | $1,564,000 | +4.3% | 35,796 | -2.5% | 0.18% | +4.8% |
| Q2 2021 | $1,499,000 | +17.6% | 36,718 | -5.5% | 0.17% | +15.2% |
| Q1 2021 | $1,275,000 | -23.9% | 38,837 | -5.8% | 0.14% | -29.3% |
| Q4 2020 | $1,676,000 | -22.7% | 41,208 | -30.4% | 0.20% | -35.5% |
| Q3 2020 | $2,167,000 | +0.0% | 59,193 | -7.4% | 0.32% | -5.6% |
| Q2 2020 | $2,166,000 | +41.5% | 63,903 | -11.6% | 0.34% | +16.6% |
| Q1 2020 | $1,531,000 | -14.7% | 72,263 | -10.1% | 0.29% | +5.5% |
| Q4 2019 | $1,795,000 | – | 80,380 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |